Dental implant company Southern Implants has received U.S. Food and Drug Administration (FDA) 510(k) clearance for two new implants.
The Zygan implant and the Oncology implant are both designed for patients with severely atrophic jaws, according to Southern Implants. The Zygan implant is a narrow, titanium implant, while the Oncology implant has a machined coronal surface. Both are part of the company's Osseointegrated Fixtures system, which includes implants in a variety of sizes.
